Cablivi Kit
Product Images NDC 58468-0225

Product Visual Gallery

This gallery contains 29 technical images submitted to the FDA as part of the official labeling for Cablivi (NDC 58468-0225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genzyme Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Cablivi 01)

Kaplan-Meier survival curve comparing platelet count response-free survival probability over time (days) between treatment groups receiving Cablivi and placebo. The graph includes number of subjects at risk at several time points and statistical results including a stratified log-rank test p-value of 0.01 and a hazard ratio of 1.55 with 95% confidence interval [1.10; 2.20].*

FDA Label Image

Figure (Cablivi 02)

Illustration depicting the contents of a Cablivi kit, including 1 vial of caplacizumab-yhdp with metal and plastic caps, 2 alcohol swabs, 1 prefilled syringe with sterile water for injection labeled with parts (plunger, barrel, plastic cap), 1 sterile vial adapter with its package, and 1 sterile needle including cap and needle safety shield. Additional supplies needed but not included are cotton balls and a sharps disposal container.*

FDA Label Image

Figure A (Cablivi 03)

Front view of a Cablivi (caplacizumab) kit carton showing the expiration date location on the bottom panel. The packaging is primarily white with teal accents and displays the labeler as Genzyme Corporation. The expiration date is printed near the bottom edge.*

FDA Label Image

Figure B (Cablivi 04)

Illustration showing two hands preparing an injection with a syringe and vial. A clock icon displays a 10-second countdown, indicating a waiting or mixing time during preparation.*

FDA Label Image

Figure C (Cablivi 05)

An instructional illustration showing a person removing the cap from a vial using their fingers. The vial likely contains a medication, held by one hand, while the other hand pulls off a green flip-top cap.*

FDA Label Image

Figure D (Cablivi 06)

An instructional illustration showing a hand holding a vial labeled as part of a medication kit, while another hand is peeling off a protective seal from the vial cap. The image likely demonstrates proper vial preparation steps for the human prescription drug Cablivi (caplacizumab) kit by Genzyme Corporation.*

FDA Label Image

Figure E (Cablivi 07)

Illustration showing hands peeling back the protective covering from a vial adapter or medical device connector, likely part of a drug reconstitution or administration kit. The detailed step highlights preparation of the device for use.*

FDA Label Image

Figure F (Cablivi 08)

An instructional diagram showing hands assembling a medication vial with a connector piece. The image illustrates placing a purple connector onto the vial's top, with an arrow indicating the direction of assembly.*

FDA Label Image

Figure G (Cablivi 09)

An instructional illustration showing hands removing a cap from a syringe or pen device, indicated by a downward arrow. The image likely demonstrates a preparation step for using a medication delivery device.*

FDA Label Image

Figure H (Cablivi 10)

An instructional illustration showing two hands removing a protective cover from a vial or cartridge, with arrows indicating the directions to press and lift the cover. The image likely relates to the preparation of the Cablivi kit for use.*

FDA Label Image

Figure I (Cablivi 11)

An instructional illustration showing a close-up of hands preparing an injection device. One hand holds a syringe or cartridge, while the other hand twists or removes a cap or cover from a vial or device, indicating a step in medication preparation.*

FDA Label Image

Figure J (Cablivi 12)

An instructional illustration showing how to push down on a syringe plunger connected to a vial or injection device, likely demonstrating preparation or use of a medication kit.*

FDA Label Image

Figure K (Cablivi 13)

An instructional illustration showing a hand holding a vial or syringe, with an arrow indicating a twisting or rotating motion. The image likely demonstrates a step involved in preparing or using Cablivi (caplacizumab) kit for administration.*

FDA Label Image

Figure L (Cablivi 14)

Instructional illustration showing the process of injecting a liquid into a vial with a syringe. A clock icon indicates a waiting time of 2 minutes, suggesting a step for mixing or letting the contents settle before further use.*

FDA Label Image

Figure M (Cablivi 15)

An instructional illustration showing how to use a syringe with a vial or cartridge. It depicts a hand holding a syringe and pushing the plunger downward, indicated by a black arrow pointing downwards. The image is likely part of usage or preparation instructions for Cablivi (caplacizumab) kit.*

FDA Label Image

Figure N (Cablivi 16)

An instructional illustration showing the assembly of a syringe and vial, depicting the syringe being inserted onto the vial's top. This image is part of the usage instructions for Cablivi (caplacizumab) kit by Genzyme Corporation.*

FDA Label Image

Figure O (Cablivi 17)

An instructional illustration showing hands assembling or attaching a cap or component to a vial, with arrows indicating a twisting motion. This diagram likely relates to the use or preparation of the Cablivi kit containing caplacizumab by Genzyme Corporation.*

FDA Label Image

Figure P (Cablivi 18)

An instructional illustration showing hands peeling back outer packaging to reveal a small vial or syringe inside. The image likely demonstrates how to open the packaging of the Cablivi kit containing caplacizumab for administration preparation.*

FDA Label Image

Figure Q (Cablivi 19)

An instructional illustration showing the process of connecting two components, one held in each hand, by aligning and twisting them together. The arrow indicates the direction of the twist for attachment.*

FDA Label Image

Figure R (Cablivi 20)

An instructional illustration showing hands opening or assembling a component of the Cablivi kit. The image depicts the removal or lifting of a protective cover from a part of a medical device or vial, indicated by a black arrow guiding the motion.*

FDA Label Image

Figure S (Cablivi 21)

An illustration showing the abdomen area of a human torso. The image highlights the injection sites on the abdomen with a circular pattern centered around the navel, indicating preferred locations for subcutaneous injection.*

FDA Label Image

Figure T (Cablivi 22)

An instructional illustration showing hands applying a small adhesive patch or sticker to the skin of a finger, demonstrating the placement or use of a product related to administration or treatment.*

FDA Label Image

Figure U (Cablivi 23)

Illustration showing two hands assembling a component, likely part of a medical device or injection kit, involving a small cylindrical piece being connected with another part featuring a hinge mechanism. An arrow indicates the direction of assembly or connection.*

FDA Label Image

Figure V (Cablivi 24)

An instructional illustration showing hands preparing a syringe connected to a vial or cartridge, likely demonstrating the preparation or reconstitution process for the Cablivi (caplacizumab) kit by Genzyme Corporation.*

FDA Label Image

Figure W (Cablivi 25)

An instructional illustration showing a hand holding a syringe and pulling on the plunger, indicated by an upward arrow, suggesting the withdrawal of fluid into the syringe.*

FDA Label Image

Figure X (Cablivi 26)

An instructional illustration showing the application of the product: a hand placing or adjusting a round adhesive patch or device on the abdomen area, likely demonstrating usage method for the Cablivi kit.*

FDA Label Image

Figure Y (Cablivi 27)

An instructional illustration depicting a person administering a subcutaneous injection using a prefilled syringe by inserting the needle into the skin on the forearm or hand area. The hands hold the syringe and skin steady during the injection process.*

FDA Label Image

Figure Z (Cablivi 28)

An instructional illustration depicting a person removing a small cap or seal from a device, likely a component of a medication delivery system, using their fingers to prepare it for use.*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for Cablivi 11 mg kit for injection containing caplacizumab-yhdp. The label specifies the product is for intravenous and subcutaneous use, must be reconstituted with the provided diluent, and is a single-dose vial. The kit includes one 11 mg Cablivi single-dose vial, one 1 mL sterile water for injection syringe, one sterile vial adapter, one hypodermic needle, and two alcohol swabs. Labeler is Genzyme Corporation, Sanofi Genzyme.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.